Document:

Mar 7 2013

 

Mr. Derek Ivany, CEO

Myriad Interactive Media Inc.

7 Ingram Drive

Suite 128

Toronto, Ontario

 

Dear Mr. Ivany,

 

This letter sets forth the bas is on which
Viral Desk, Inc. an independent contractor ("Viral Desk") is engaged by Myriad Interactive Media Inc. (the "Company")
to act as a consultant for ongoing social media management for Myriad-MingleSuite clients, for a one-year period beginning on April
1st 2013.

 

		1.	Nature of Services

 

ViralDesk shall provide the following services:

 

		(a)	Advise the Company with respect to its strategic planning process
and business plans including a full comprehensive analysis of markets, positioning, financial models, organization structure, potential
strategic alliances and regulatory requirements in the USA

		(b)	Assist the Company in business development activities including the
introduction of potential new social media clients whom may be interested in using the Mingle Suite technology

		(c)	Work closely with the Company's management to develop a set of short-term
goals with special focus on selling the Mingle Suite technology

		(d)	ViralDesk will assist the Company in identifying companies and partners
in the targeted industries, which may include public companies, divisions of public companies, and privately held companies, and
after evaluating such companies, assist in contacting these company' s and providing both a demo of the MingleSuite technology
as well as manage their daily social media activity.

 

Specific Services

 

		(a)	Business Development in the USA

		(b)	Social Media Management & Technology Sales

		(c)	Company marketing and positioning strategies

		(d)	Comprehensive market research & reporting

 

    	 

    	 

    

 

		2.	Compensation for Services

 

		(a)	In consideration for the above described services, the Company agrees
to issue to a Network or its designees 5,000,000 common shares of Myriad Interactive Media Inc. registered under SEC Rule S-8 in
lieu of cash 

 

		3.	Indemnity

 

Each party shall indemnify the other and its
partners, officers, directors, and employees against all claims, damages, liability, and litigating expenses (including the expense
of investigation and defending such claims) as the same as incurred, relating to or arising out of its activities hereunder, except
to the extent that any claims, damages, liability, or expense, if found on a fin al judgment by a court of law to have resulted
from the other's willful misconduct or gross negligence in performing the services described above.

 

		4.	Termination

 

This agreement may be terminated after six
months by either party at the end of subsequent calendar month. The terminating party shall give written notice to the other party
at least fifteen days prior to such termination. However, all shares issued pursuant to this agreement will remain in effect.

 

		5.	Entire Agreement

 

This agreement sets forth the entire understanding
of the parties relating to the subject matter hereof, and supersedes and cancels any prior communications, understanding, and agreements
between the parties. This agreement cannot be modified or changed, nor can any of its provisions be waived, except in writing signed
by a ll parties.

 

		6.	Governing Law .

 

This agreement shall be governed by the laws
of the State of Nevada. The parties hereto agree to submit to the jurisdiction of the Nevada district courts for the determination
of any dispute arising this agreement or in any action to enforce the terms hereof.

 

Please confirm the foregoing is in accordance
with your understanding by signing and returning to us the duplicate of this letter.

 

Accepted and Agreed to:

	
        By: /s/ Derek Ivany

        Derek Ivany

        Ch ief Executive Officer

        Myriad Interactive Media Inc.

         
	
        By: /s/ Sergii Petryk

         

        Sergii Petryk

        President

        Viral Desk, Inc.

	
        By: /s/ Hercules Galang

        Hercules Galang

        Ch ief Executive Officer

        Myriad Interactive Media Inc.
	

 

    	2EX-10.1

EXECUTION VERSION

AMENDMENT NO. 3 TO MERGER AGREEMENT AND PLAN OF REORGANIZATION

This Third Amendment to Merger Agreement and Plan of Reorganization (this “Third Amendment”), is
made as of the 14th day of March, 2013 (the “Effective Date”), by and among Immune Pharmaceuticals
Ltd. (“Immune”) EpiCept Corporation, a Delaware corporation, and EpiCept Israel Ltd., an Israeli
company (together, “EpiCept” and collectively with Immune, the “Parties”). Capitalized terms used
herein and not otherwise defined shall have the respective definitions ascribed to them in the
Merger Agreement and Plan of Reorganization, dated November 7, 2012 (the “Merger Agreement”), as
amended on November 27, 2012 (the “First Amendment”) and on February 11, 2013 (the “Second
Amendment”).

	 	 	 
	WHEREAS,
	 	The Parties have entered into the Merger Agreement; and

	WHEREAS,
	 	The Parties desire to clarify the Private Placement and the dilutive

effect of the Private Placement Securities; and

	WHEREAS,
	 	The Parties desire to modify the definition of “Company Financial

Statements and extend the date that the Company Financial Statements

shall be provided to Parent; and

	WHEREAS,
	 	The Parties desire to amend the Merger Agreement, as further set

forth herein.

NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein, the
Parties hereby agree as follows:

	 	1.	 	The definition of the term “Private Placement” as defined in the Merger Agreement, and as
amended in the First Amendment, shall be amended by replacing the words “the offering of
securities” with “one or more private offerings of securities that are exempt from
registration with SEC” and adding the words “, which are consummated following the date of
this Agreement” to the end of such definition.

	 	2.	 	The definition of the term “Private Placement Securities” as defined in the Merger
Agreement shall be amended by replacing the words “of Parent” with the words “of Parent or
Company”.

	 	3.	 	The definitions of “Lead Investment Bank” and “Private Placement Memorandum” shall be
deleted.

	 	4.	 	The second sentence of Section 2.5(b) of the Merger Agreement shall be deleted and
replaced with the following sentence:

“Without derogating from the above, it is clarified that upon consummation of the
Merger, any Private Placement Securities issued following the date of this
Agreement will dilute the Existing Company Shareholders and the stockholders of
Parent on a pro rata basis.”

The third sentence of Section 2.5(b) of the Merger Agreement shall be deleted in its
entirety.

The fourth sentence of Section 2.5(b) of the Merger Agreement shall be amended by
replacing the words “$9,000,000 (as increased after March 31, 2013 by an amount equal to
one-half of the Adjustment)” with “$10,000,000”.

In addition, the fifth sentence of Section 2.5(b) of the Merger Agreement shall be
deleted in its entirety.

	 	5.	 	The last sentence of new Section 2.5(b)(A) referenced in Paragraph 1 of the Second
Amendment shall be deleted and replaced with the following sentence:

“Any references in this Agreement to the term “Adjustment” shall mean the
Additional Adjustment.”

	 	6.	 	Section 3.25(a) of the Merger Agreement, as amended in the Second Amendment, shall be
deleted and the following is substituted in lieu thereof:

“(a) The Company has agreed to use its best efforts to deliver to Parent on or
before April 15, 2013, copies of the audited balance sheets of the Company and the
audited statements of operations, and audited changes in shareholders’ equity and
cash flows, through December 31, 2012, required for the proxy statement or
Registration Statement on Form S-4 (collectively, the “Company Financial
Statements”). The Company Financial Statements (including the related notes) will
be prepared in accordance with GAAP during the periods involved, and will present
fairly the consolidated financial position of the Company as of the respective
dates set forth therein, and the consolidated results of the Company’s operations
and its cash flows for the respective periods set forth therein in accordance with
GAAP.”

	 	7.	 	The first sentence of Section 5.18(b) of the Merger Agreement, as amended in the Second
Amendment, shall be amended by replacing the words “February 28, 2013” with “April 15,
2013”.

	 	8.	 	Section 10.1(c)(iii) of the Merger Agreement, as amended in the Second Amendment, shall
be deleted and replaced with the following:

“If the Company does not deliver to Parent the Company Financial Statements on or
before April 15, 2013.”

	 	9.	 	Section 10.1(d)(iii) of the Merger Agreement is amended by replacing the words
“$9,000,000 (as increased after March 31, 2013 by an amount equal to one-half of the
Adjustment)” with “$10,000,000”.

	 	10.	 	The first sentence of Section 5.19 of the Merger Agreement shall be deleted and replaced
with the following sentence:

“Promptly after execution of this Agreement, Parent and/or Company shall commence
the Private Placement, each of which shall be subject to the Company’s control.”

In addition, the second sentence of Section 5.19 of the Merger Agreement shall be
amended by replacing the words “Any funds raised” with “Any Private Placement Securities
issued”.

	 	11.	 	The first sentence in Section 5.22 of the Merger Agreement shall be deleted and the
second sentence of Section 5.22 of the Merger Agreement shall be amended by replacing the
word “thereof” with “of the Private Placement”.

	 	12.	 	Unless amended hereby, all provisions of the Merger Agreement, the First Amendment and
the Second Amendment shall remain in full force and effect.

[The remainder of this page intentionally left blank]

1

IN WITNESS WHEREOF, the Parties hereto have executed this Third Amendment as of the Effective Date.

EPICEPT CORPORATION

By:      

Name: Robert W. Cook

Title: President

EPICEPT ISRAEL LTD.

BY: EPICEPT CORPORATION

By:      

Name: Robert W. Cook

Title: President

IMMUNE PHARMACEUTICALS LTD.

By:      

Name: Dr. Daniel Gedeon Teper

Title: Chief Executive Officer

Signature Page to

Third Amendment to Merger Agreement and Plan of Reorganization

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]